EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation

Kevin X Liu, Mia Salans, Teresa P Easwaran, Christina Phuong, Kee Kiat Yeo, Hesham Elhalawani, Paul J Catalano, Kathryn Dusenbery, Karen J Marcus, Stephanie A Terezakis, Daphne A Haas-Kogan, Steve E Braunstein

Journal of Neuro-Oncology · 2025

DOI: 10.1007/s11060-025-04975-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Kevin X Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Bos…. Hauptthemen laut MEDLINE: Ependymoma, Salvage Therapy, Photons, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health Loan Repayment Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We characterized the association between photon radiation dose (< 59.4 versus ≥ 59.4 Gy) and outcomes in intracranial ependymoma. We also examined factors associated with survival after relapse.

Methods

This multi-institutional retrospective study included patients age ≤ 21 years who received postoperative definitive-intent photon radiotherapy for posterior fossa ependymoma between 1997 and 2021. Clinical characteristics were obtained from medical records. Five-year overall (OS) and progression-free (PFS) survival were estimated using the Kaplan-Meier method. Factors associated with progression after radiotherapy, including dose < 59.4 versus ≥ 59.4 Gy, were analyzed using Fine and Gray’s proportional subhazards model. Factors associated with post-relapse survival were explored using the Cox proportional-hazards model.

Results

We identified 45 patients meeting inclusion criteria; 48.9% received ≥ 59.4 Gy. There was no difference in 5-year OS or PFS between those who received < 59.4 Gy versus ≥ 59.4 (OS 49.0% vs. 82.9%, p = 0.11; PFS 36.4% vs. 63.9%, p = 0.08); however, there was a trend towards worse 5-year OS and PFS among patients with grade 2 ependymoma who received < 59.4 Gy (OS 48.8% vs. 88.9%, p = 0.06, PFS 40.0% vs. 83.1%, p = 0.08). Only age > 4 years at diagnosis (subdistribution hazard ratio [SHR]: 0.40, p = 0.03) was associated lower risk of progression. Following radiotherapy, 24 patients relapsed. Receipt of salvage systemic therapy was associated with worse post-relapse OS on multivariable analysis (HR = 2.84, p = 0.04).

Conclusion

Underlying biological factors such as age and molecular subtype may hold greater prognostic significance than radiation dose in pediatric ependymoma. Regardless, recurrences are common and outcomes remain poor. Further research into optimal management of relapsed disease is critical.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpendymomaSalvage TherapyPhotonsNeoplasm Recurrence, LocalBrain NeoplasmsInfratentorial NeoplasmsHumansFemaleMaleAdolescentChildRetrospective StudiesChild, PreschoolYoung AdultRadiotherapy DosageFollow-Up StudiesInfantSurvival RatePrognosis

Stichwörter der Autor:innen

Adjuvant radiationIntracranial ependymomaRadiation doseRelapsed ependymoma

Autor:innen und Institutionen

  • Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Radiation Oncology, University of California at San Francisco and UCSF Benioff Children's Hospital, 1600 Divisadero St., Suite H1031, San Francisco, CA, 94143-1708, USA.
  • Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
  • Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
  • Department of Biostatistics, Department of Biostatistics and Computational Biology, Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Department of Radiation Oncology, University of California at San Francisco and UCSF Benioff Children's Hospital, 1600 Divisadero St., Suite H1031, San Francisco, CA, 94143-1708, USA. Steve.Braunstein@ucsf.edu.

Förderung

  • NCI NIH HHS
  • National Institutes of Health Loan Repayment Program

Zitieren

APA

Liu, K. X., Salans, M., Easwaran, T. P., Phuong, C., Yeo, K. K., Elhalawani, H., Catalano, P. J., Dusenbery, K., Marcus, K. J., Terezakis, S. A., Haas-Kogan, D. A., & Braunstein, S. E. (2025). The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-025-04975-5

Vancouver

Liu KX, Salans M, Easwaran TP, Phuong C, Yeo KK, Elhalawani H, et al. The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-025-04975-5

BibTeX
@article{Liu2025,
  author = {Liu, Kevin X and Salans, Mia and Easwaran, Teresa P and Phuong, Christina and Yeo, Kee Kiat and Elhalawani, Hesham and Catalano, Paul J and Dusenbery, Kathryn and Marcus, Karen J and Terezakis, Stephanie A and Haas-Kogan, Daphne A and Braunstein, Steve E},
  title = {The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation},
  journal = {Journal of Neuro-Oncology},
  year = {2025},
  doi = {10.1007/s11060-025-04975-5}
}
Kostenlos starten →